The important question inevitably becomes whether the risk of extrapyramidal side effects (EPSs) with non-sedating neuroleptics is greaternthen the risk of carsiovascular and other side effects with drugs such as thioridazine. This question cannot be answered reliably from study data and must still be decided on a case by case basis by informed clinicians.